Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy

Clinical trial NCT03719131 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03719131
Sponsor: Emory University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Melanoma, Stage III Cutaneous Melanoma, Stage IV Stage III Melanoma Stage IIIA Skin Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma Unresectable Melanoma

Start date: 2019-06-05
Primary completion: 2022-09-27
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.